These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15899580)

  • 1. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity.
    Ikezawa Y; Nakazawa M; Tamura C; Takahashi K; Minami M; Ikezawa Z
    J Dermatol Sci; 2005 Aug; 39(2):105-12. PubMed ID: 15899580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide-modified murine peritoneal macrophages induce CD4
    Majewska-Szczepanik M; Kowalczyk P; Biała D; Marcińska K; Strzępa A; Woźniak D; Sura P; Pearson J; Wen L; Szczepanik M
    Pharmacol Rep; 2018 Aug; 70(4):796-803. PubMed ID: 29957340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
    Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide.
    Motoyoshi Y; Kaminoda K; Saitoh O; Hamasaki K; Nakao K; Ishii N; Nagayama Y; Eguchi K
    Oncol Rep; 2006 Jul; 16(1):141-6. PubMed ID: 16786137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial recruitment of interferon-gamma-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced murine contact hypersensitivity reactions.
    Okazaki F; Kanzaki H; Fujii K; Arata J; Akiba H; Tsujii K; Iwatsuki K
    J Dermatol; 2002 Nov; 29(11):699-708. PubMed ID: 12484431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.
    Lutsiak ME; Semnani RT; De Pascalis R; Kashmiri SV; Schlom J; Sabzevari H
    Blood; 2005 Apr; 105(7):2862-8. PubMed ID: 15591121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.
    Zhao J; Cao Y; Lei Z; Yang Z; Zhang B; Huang B
    Cancer Res; 2010 Jun; 70(12):4850-8. PubMed ID: 20501849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cyclophosphamide and irradiation on cells which suppress contact sensitivity in the mouse.
    Zembala M; Asherson GL
    Clin Exp Immunol; 1976 Mar; 23(3):554-61. PubMed ID: 1084814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Graves' hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model.
    Saitoh O; Nagayama Y
    Endocrinology; 2006 May; 147(5):2417-22. PubMed ID: 16439459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: functional roles of interleukin-5-producing CD4(+) lymphocytes.
    Sasaki G; Satoh T; Yokozeki H; Katayama I; Nishioka K
    Cell Immunol; 2000 Aug; 203(2):124-33. PubMed ID: 11006010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.
    Nakamura K; Kitani A; Strober W
    J Exp Med; 2001 Sep; 194(5):629-44. PubMed ID: 11535631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population.
    Gautam SC; Chikkala NF; Battisto JR
    Cell Immunol; 1990 Feb; 125(2):437-48. PubMed ID: 2137034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
    Ghiringhelli F; Larmonier N; Schmitt E; Parcellier A; Cathelin D; Garrido C; Chauffert B; Solary E; Bonnotte B; Martin F
    Eur J Immunol; 2004 Feb; 34(2):336-44. PubMed ID: 14768038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis.
    Miyauchi A; Hiramine C; Tanaka S; Hojo K
    Tohoku J Exp Med; 1990 Oct; 162(2):147-67. PubMed ID: 2129070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate CD4+CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation.
    Dubois B; Chapat L; Goubier A; Papiernik M; Nicolas JF; Kaiserlian D
    Blood; 2003 Nov; 102(9):3295-301. PubMed ID: 12855551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice.
    Chen X; Oppenheim JJ; Howard OM
    J Leukoc Biol; 2005 Jul; 78(1):114-21. PubMed ID: 15845645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early events in peripheral regulatory T cell induction via the nasal mucosa.
    Unger WW; Hauet-Broere F; Jansen W; van Berkel LA; Kraal G; Samsom JN
    J Immunol; 2003 Nov; 171(9):4592-603. PubMed ID: 14568933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin application of ketoprofen systemically suppresses contact hypersensitivity by inducing CD4(+) CD25(+) regulatory T cells.
    Atarashi K; Mori T; Yoshiki R; Kabashima K; Kuma H; Tokura Y
    J Dermatol Sci; 2009 Mar; 53(3):216-21. PubMed ID: 19157794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.